课题基金 / 基金详情

HUMAN LYMPHOCYTES CLONALLY TRANSFORMED BY EBV

HUMAN LYMPHOCYTES CLONALLY TRANSFORMED BY EBV
EBV 克隆转化的人类淋巴细胞
批准号:
3173120
负责人:
Nathaniel A. Brown
金额:
$10.23万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 1986-12-31

项目摘要

项目成果

Nathaniel A. Brown的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The precise ontogenetic range of human lymphocytes susceptible to transformation by Epstein-Barr Virus (EBV) has not been defined. Recent but incomplete evidence suggests that EBV may transform a range of B-lymphocyte phenotypes, from "early" (non-Ig producing) B-cells through pre-B cells and B-cells. Analyses of Ig expression and cytogenetic phenomena in Burkitt tumor cells suggest that the oncogenic event which distinguishes them from other EBV-transformed cells may be associated with a particular stage in their Ig-gene differentiation program. This oncogenic event may include a human c-myc gene translocation. We will attempt to better define the ontogenetic range of human lymphocytes susceptible to EBV-mediated transformation. Primary mononuclear cells from human fetal, neonatal, and adult tissues will be clonally transformed in agarose medium. Clonally propagated lines will then be phenotyped by analysis of Ig expression, surface "Ia" antigen, and other surface epitopes. Karyotype analyses will also be done. The cell clones will then be analyzed for their patterns of Ig gene rearrangements. Cell clones with aberrant rearrangements of non-expressed Ig gene alleles will be examined for evidence of rearrangement of the cellular c-myc gene, or chromosomal translocation. The results of our studies should yield a clearer picture of the stages of human (B-) lymphocyte ontogeny which are susceptible to transformation by EBV. We may be able to partially illuminate how clinically malignant B-cell clones emerge from a polyclonally transformed population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL L-NUCLEOSIDE COMBINATION ANTI-HBV THERAPY
  • 批准号:
    6344473
  • 项目类别:
  • 资助金额:
    $58.95万
  • 财政年份:
    2001
  • 负责人:
    Nathaniel A. Brown
  • 依托单位:
NOVEL L-NUCLEOSIDE COMBINATION ANTI-HBV THERAPY
  • 批准号:
    6536053
  • 项目类别:
  • 资助金额:
    $40.42万
  • 财政年份:
    2001
  • 负责人:
    Nathaniel A. Brown
  • 依托单位:
CLONAL VIRULENCE FEATURES OF THE EBV TERMINAL REGION
  • 批准号:
    3173122
  • 项目类别:
  • 资助金额:
    $2.64万
  • 财政年份:
    1987
  • 负责人:
    Nathaniel A. Brown
  • 依托单位:
CLONAL VIRULENCE FEATURES OF THE EBV TERMINAL REGION
  • 批准号:
    3173123
  • 项目类别:
  • 资助金额:
    $9.66万
  • 财政年份:
    1987
  • 负责人:
    Nathaniel A. Brown
  • 依托单位:
海外基金